CancerDrs Find care

Thyroid Cancer clinical trials in New Jersey

8 actively recruiting thyroid cancer trials at 16 sites across New Jersey.

Data from ClinicalTrials.gov · last refreshed

Phase 1, Phase 2 Recruiting Industry

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with adv…

Sponsor: Turning Point Therapeutics, Inc.
NCT ID: NCT03093116
Sites in New Jersey:
  • Local Institution - 2122 — New Brunswick, New Jersey
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

The researchers are doing this study to find out if the combination of avutometinib and defactinib is an effective treatment for RAF dimer-driven radioiodine-refractory differentiated thyroid cancer or anaplastic thyroid cancer. The resear…

Sponsor: Memorial Sloan Kettering Cancer Center
NCT ID: NCT06007924
Sites in New Jersey:
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale, New Jersey
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two par…

Sponsor: Pfizer
NCT ID: NCT05538130
Sites in New Jersey:
  • MSK Basking Ridge. — Basking Ridge, New Jersey
  • MSK Monmouth. — Middletown, New Jersey
  • MSK Bergen. — Montvale, New Jersey
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines in people with solid tumors. This study is …

Sponsor: Pfizer
NCT ID: NCT05355701
Sites in New Jersey:
  • MSK Monmouth — Middletown, New Jersey
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

SLV-154 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with metastatic solid tumors.

Sponsor: Solve Therapeutics
NCT ID: NCT06771219
Sites in New Jersey:
  • Astera Cancer Care — East Brunswick, New Jersey
View on ClinicalTrials.gov →
Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in New Jersey:
  • Englewood Hospital and Medical Center — Englewood, New Jersey
  • CentraState Medical Center — Freehold, New Jersey
  • Hackettstown Medical Center — Hackettstown, New Jersey
  • Morristown Medical Center — Morristown, New Jersey
  • Inspira Medical Center Mullica Hill — Mullica Hill, New Jersey
View on ClinicalTrials.gov →
NA Recruiting Academic/Other

A Study of Multiparametric Ultrasound Imaging Methods

The researchers are doing this study to see how well a type of ultrasound imaging called multiparametric ultrasound (mpUS), can be used to examine, evaluate, and provide information about different cancerous and non-cancerous tissue. The r…

Sponsor: Memorial Sloan Kettering Cancer Center
NCT ID: NCT07270237
Sites in New Jersey:
  • Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Consent Only) — Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Consent Only) — Montvale, New Jersey
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20